Table 4.

Correlation of CBX members mRNA expression level with OS and PFS in different chemotherapy of ovarian cancer patients

CBX	chemotherapy	OS			PFS
		Cases	HR (95% CI)	P value	Cases	HR (95% CI)	P value
CBX1	Platin	1409	1.37 (1.18 - 1.59)	0.0000*	1259	1.43 (1.24 - 1.64)	0.0000*
	Taxol	793	1.44 (1.18 - 1.77)	0.0004*	715	1.23 (1.02 - 1.49)	0.0271*
	Taxol+Platin	776	1.45 (1.18 - 1.78)	0.0003*	698	1.24 (1.03 - 1.50)	0.0262*
CBX2	Platin	478	1.28 (0.99 - 1.66)	0.0570	502	0.82 (0.66 - 1.01)	0.0669
	Taxol	357	0.84 (0.62 - 1.16)	0.2938	381	0.75 (0.59 - 0.95)	0.0167*
	Taxol+Platin	356	0.84 (0.61 - 1.15)	0.2850	380	0.75 (0.59 - 0.95)	0.0183*
CBX3	Platin	1409	1.23 (1.06 - 1.42)	0.0068*	1259	1.26 (1.09 - 1.46)	0.0022*
	Taxol	793	1.27 (1.05 - 1.55)	0.0161*	715	1.11 (0.93 - 1.32)	0.2399
	Taxol+Platin	776	1.30 (1.06 - 1.59)	0.0112*	698	1.13 (0.94 - 1.34)	0.1845

*P <0.05.